Johnson & Johnson launches faster coronary IVL catheter in the U.S.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half
October 20, 2026 7:45 AM EDTNext-generation intravascular lithotripsy (IVL) catheter delivers pulses at 2 Hz, improving efficiency in calcium modification treatment of coronary artery disease1 Faster pulsing reduces duration patients may experience procedure-induced ischemic time2 Shockwave C2 Aero Fly builds on the best-in-class features of Shockwave C2 Aero, featuring leading deliverability, crossability and repositioning capabilities3
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) announced today the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL Catheter designed to treat a broad range of... More



